These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35977581)

  • 1. Catheter Ablation of Well Tolerated Ventricular Tachycardia in Patients With Structural Heart Disease and Without Automatic Defibrillator Implantation: Long Term Follow-up.
    Cardelli LS; Barbato G; Carinci V; Pergolini F; Leci E; Casella G
    Curr Probl Cardiol; 2022 Dec; 47(12):101349. PubMed ID: 35977581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.
    Maury P; Baratto F; Zeppenfeld K; Klein G; Delacretaz E; Sacher F; Pruvot E; Brigadeau F; Rollin A; Andronache M; Maccabelli G; Gawrysiak M; Brenner R; Forclaz A; Schlaepfer J; Lacroix D; Duparc A; Mondoly P; Bouisset F; Delay M; Hocini M; Derval N; Sadoul N; Magnin-Poull I; Klug D; Haïssaguerre M; Jaïs P; Della Bella P; De Chillou C
    Eur Heart J; 2014 Jun; 35(22):1479-85. PubMed ID: 24536081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular tachycardia ablation as an alternative to implantable cardioverter-defibrillators in patients with preserved ejection fraction: current status and future prospects.
    Maury P; Beneyto M; Mondoly P; Delasnerie H; Rollin A
    Expert Rev Med Devices; 2022 May; 19(5):423-430. PubMed ID: 35686666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.
    Tung R; Xue Y; Chen M; Jiang C; Shatz DY; Besser SA; Hu H; Chung FP; Nakahara S; Kim YH; Satomi K; Shen L; Liang E; Liao H; Gu K; Jiang R; Jiang J; Hori Y; Choi JI; Ueda A; Komatsu Y; Kazawa S; Soejima K; Chen SA; Nogami A; Yao Y;
    Circulation; 2022 Jun; 145(25):1839-1849. PubMed ID: 35507499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency catheter ablation of ventricular tachycardia following implantation of an automatic cardioverter defibrillator.
    Willems S; Borggrefe M; Shenasa M; Chen X; Hindricks G; Haverkamp W; Wietholt D; Block M; Breithardt G
    Pacing Clin Electrophysiol; 1993 Aug; 16(8):1684-92. PubMed ID: 7690937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term benefit of first-line peri-implantable cardioverter-defibrillator implant ventricular tachycardia-substrate ablation in secondary prevention patients.
    Acosta J; Cabanelas N; Penela D; Fernández-Armenta J; Andreu D; Borràs R; Korshunov V; Cabrera M; Vasanelli F; Arbelo E; Guasch E; Martínez M; Tolosana JM; Mont L; Berruezo A
    Europace; 2017 Jun; 19(6):976-982. PubMed ID: 27353322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up after hemodynamically not tolerated ventricular tachycardia in patients with midrange reduced to normal ejection fraction: A retrospective single-centre case series.
    Groeneveld SA; Blom LJ; van der Heijden JF; Loh P; Hassink RJ
    Eur J Clin Invest; 2021 Jan; 51(1):e13359. PubMed ID: 32705678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.
    Willems S; Tilz RR; Steven D; Kääb S; Wegscheider K; Gellér L; Meyer C; Heeger CH; Metzner A; Sinner MF; Schlüter M; Nordbeck P; Eckardt L; Bogossian H; Sultan A; Wenzel B; Kuck KH;
    Circulation; 2020 Mar; 141(13):1057-1067. PubMed ID: 32000514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency catheter ablation of postinfarction ventricular tachycardia: long-term success and the significance of inducible nonclinical arrhythmias.
    Rothman SA; Hsia HH; Cossú SF; Chmielewski IL; Buxton AE; Miller JM
    Circulation; 1997 Nov; 96(10):3499-508. PubMed ID: 9396447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of cardiac magnetic resonance imaging and programmed ventricular stimulation in patients with frequent premature ventricular complexes undergoing radiofrequency ablation.
    Yokokawa M; Siontis KC; Kim HM; Stojanovska J; Latchamsetty R; Crawford T; Jongnarangsin K; Ghanbari H; Cunnane R; Chugh A; Pelosi F; Oral H; Morady F; Bogun F
    Heart Rhythm; 2017 Nov; 14(11):1695-1701. PubMed ID: 28688990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter ablation of incessant ventricular tachycardia: acute and long-term results.
    Cao K; Gonska BD
    Eur Heart J; 1996 May; 17(5):756-63. PubMed ID: 8737107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year outcomes of monomorphic ventricular tachycardia catheter ablation in repaired tetralogy of Fallot.
    Laredo M; Frank R; Waintraub X; Gandjbakhch E; Iserin L; Hascoët S; Himbert C; Gallais Y; Hidden-Lucet F; Duthoit G
    Arch Cardiovasc Dis; 2017 May; 110(5):292-302. PubMed ID: 28347634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator.
    Sauer WH; Zado E; Gerstenfeld EP; Marchlinski FE; Callans DJ
    Heart Rhythm; 2010 Jan; 7(1):9-14. PubMed ID: 19939743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sustained monomorphic ventricular tachycardia in patients with structural heart disease. Different arrhythmogenic substrates, different options of palliative and curative treatment in the era of three-dimensional mapping].
    Fiala M; Chovanzík J; Neuwirth R; Nykl I; Szymeczek H; Nevralová R; Jiravský O; Branny M
    Vnitr Lek; 2006 Jun; 52(6):577-89. PubMed ID: 16871761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.